As of January 30, 2026, Nembutal, the brand name for pentobarbital sodium, is a potent short-acting barbiturate with extremely limited and highly regulated applications in medical and veterinary contexts. This drug depresses central nervous system activity by enhancing GABA receptor function, leading to sedation, hypnosis, anesthesia, and, at high doses, respiratory arrest and death. Historically […]